MODERN ASPECTS OF DIAGNOSTIC GASTROESOPHAGEAL REFLUX DISEASE
DOI:
https://doi.org/10.11603/1811-2471.2017.v0.i2.7748Keywords:
gastroesophagealreflux disease, diagnostic, gastrofibroduodenoscopy.Abstract
SUMMARY. Gastroesophageal reflux disease is an extremely common disease caused by violation motor-evacuatory function of organs of gastroesophageal zone, characterized by spontaneous reproach of gastric or duodenal contents in esophagus which lead to defeat distal department with development inflammatory and erosive-ulcerous lesions. Among adults prevalence of gastroesophageal reflux disease is 40 %.
The aim of the work – to analyze modern views of scientists and show general methods of diagnostic gastroesophageal reflux disease.
In the diagnostics of gastroesophageal reflux disease we need to focus on recommendation of Monreal consentus whereby disease can be diagnosed in the presence of at least of 3 critters: typical symptoms of disease, instrumental confirmation presence of pathology gastroesophageal reflux in people with gastrophageal reflux disease symptoms, mucosal changes of esophagus, histology study biopsy.
In accordance with IV Maastrihts consensus recommended to eradication Helicobacter pylori regardless a presence or absence of symptoms of gastroesophageal reflux disease in the presence of direct hits.
Diagnosis of gastroesophageal reflux disease established on the basis clinical criterion if patients are concerned pyrosis more than 2 times a week for 3 month or more. For the diagnostic of gastroesophageal reflux disease we offеred omeprazole and alginate tests. Display for the esophagogastroduodenoscopy in patients with gastroesophageal reflux disease availability of symptoms (dysphagia, nausea, bleeding, weigth loss, inefficiency of frial treatment (negative omeprazole and alginate tests), long course of disease, more than 50 years. Esophagogastroduodenoscopy serve to identify or exclusion significant damage in some cases. With typical symptoms no meal to take before the esophagogastroduodenoscopy to make the esophagus for the diagnostics of eosinophily esophagitis. To quantify of influence acid on the esophagus evaluation between pyrosis and reflux episodes, use ph-metry in esophagus or impedance-metry for 24 hours. Esophagus impedance use in the patients with persistent symptoms of reflux, who respectively meet the standard therapy, to assess acid and non-acid reflux disease. To identify minimal lesions mucous of asophagus in patients with gastroesophageal reflux disease. Use chromoscopy, endoscopy with high quality and zoom, narrow spectral endoscopy.
Conclusions. So, the main method of diagnostic gastroduodenal reflux disease is gastrofibroduodenoscopy. Modern endoscopstechnology make it possible to diagnose gastroesophageal reflux disease on early stage. Future prospects for further rescarch is to explore new methods of diagnostic, therapy and prevention gastroduodenal reflux disease.
References
Boeskxstaens, G., Ei-Serag, H. B., Smout, A. G., & Kahrilas, P. J. (2015). Republished: symptomatic reflux disease: the present, the past and the future. Postgrad. Med. J. 91, (107), 46−54.
Kokorina, V. Ye. (2010). Diahnostika i lecheniye zabolevaniy LOR-organov, obuslovlennykh hastroezofahealnoy refliuksnoy bolezniu [Diagnosis and treatment of ENT diseases caused by gastroesophageal reflux disease]. Extended abstract of Doctor’s thesis. Snkt. Pt., 256 [in Russian].
Tkach, S. M. (2009). Yevropeyskiye i amerykanskiye rekomendatsii po lecheniyu Tkach GERKh: prakticheskiye uroky [European and American recommendations for the treatment of GRD: practical lessons]. Healthy Ukraine – Здоров’я України, 6/1, 20 [in Russian].
Krylova, O.O., Maykova, T.V., Kutniak, V.M., Yershova, S. Yu. & Shchudro, S. O. (2016). Endoskopichna diahnostyka hastroezofahealnoi refliuksnoi khvoroby [Endoscopic diagnosis of gastroesophageal reflux disease]. Suchasna hastroenterolohiia – Modern Gastroenterology, 6, (92), 109−118 [in Ukrainian].
Kochuyeva, M. N. (2015). Hastroezofahealnaya refluksnaya bolezn: k voprosu o povyshenii effektivnosti terapii [Gastroesophageal reflux disease: to the question of increasing the effectiveness of therapy]. Ukrainskyi chasopys – Ukrainian journal, 3, 59−62 [in Russian].
Balukova, Ye. V. & Uspenskiy, Yu. P. (2015). Korrektsiya osnovnykh klinicheskikh proyavleniy hastroezofahealnoy refluksnoy bolezni [Correction of the main clinical manifestations of gastroesophageal reflux disease]. RMZh, 21, 1278−1280 [in Ukrainian].
Solomentseva, T. A., Kushnir, N. Ye., & Chernova, V. M. (2017). Mekhanizmy povrezhdeniya slizistoy obolochky pyshchevoda u bolnykh hastroezofahealnoy refluksnoy boleznyu s soputstvuyushchey ishemicheskoy boleznyu serdtsa [Mechanisms of damage to the mucosa of the esophagus in patients with gastroesophageal reflux disease with concomitant ischemic heart disease]. Suchasna hastroenterolohiia – Current gastroenterology, 1, (93), 91−98 [in Ukrainian].
Fadieienko, H. D., Halchinska, V. Yu. & Kushnir, I. Ye. (2016). Porushennia funktsionalnoho stanu sydoteliiu ta yoho rol v patohenezi hastroezofahealnoi refluksnoi khvoroby v poyednanni z ishemichnoyu khvoroboiu sertsia [Violation of the functional state sydoteliyu and its role in the pathogenesis of gastroesophageal reflux disease combined with coronary heart disease]. Suchasna hastroenterolohiia – Current gastroenterology, 5, (91), 5−10 [in Ukrainian].
Davenport, A. P., Hyndman, K. A., & Dhaun, C. N. (2016). Endothelin Published online.
Tkach, S. M. (2017). Osobennosti lecheniya hastroezofahealnoy refluksnoy bolezny pry nedostatochnoy effektivnosti inhibitorov protonnoy pompy [Features of treatment of gastroesophageal reflux disease with insufficient effectiveness of proton pump inhibitors]. Suchasna hastroenterolohiia – Current gastroenterology, 1, (93), 71−79 [in Russian].
Heidelbaugh, J. Gastroesophageal Reflux Disease (GERD) UMHS GERD Guideline, September 2013.−https // www guideline.gov / summaries /summary / 37564.
He, S., Liu, Y., & Chen, Y. (2016). Value of the Gastroesophageal Reflux Disease Ouestionnaire (GerdO) in predicting the proton pump inhibitor response in coronary artery disease patients with gastroesophageal reflux − related chest pain || Dis. Esophagus, 29, (4), 367–376.
Malfertheiner P., Megraud F., & O’Morain C.A. (2012). European Helicobacter Study Group Management of Helicobacter pylori infection − the Maastricht 1V. Florence Consensus Report. Gut, 61 (5), 646−664.
Hunt, R., Armstrong, D., & Katelaris, P. (2015). Global Perspective on Gastroesophageal Reflux Disease // World Gastroenterojogy Organisation Global Guidelines. http //www Guidelines Global Guidelines: GERD: Englich.
Chander, B., Hanley-Williams, N., Deng, Y., & Sheth, A. (2012). 24 Versus 48-hour bravо pH monitoring. J. Clin. Gastroenterol, 46, 197−200.
Boeckxstaens, G.,E., & Smout, A. (2010). Systematic rewiev role of acid, weakly acidic and weakly alkaline reflux in gastro-ocsophageal reflux disease. Aliment. Pharmacol. Ther., 32, 334−345.
De Bortoli, N., Martinucci, I., & Bertani, I. (2016). Esophageal testing; What we have so far ||Wordl J. Gastrointest Pathophysiol., 7, (1), 72−85.
